[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Decibel Therapeutics Inc (DBTX)

Decibel Therapeutics Inc (DBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DBTX, CPRI, CEQP, ESTE

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CPRI : 18.53 (-0.86%)
DBTX : 4.91 (-0.81%)
CEQP : 28.26 (+4.36%)
ESTE : 21.17 (+0.47%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRHC, VRTV, CTG, DBTX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

VRTV : 169.99 (+0.02%)
CTG : 10.50 (+0.10%)
DBTX : 4.91 (-0.81%)
TRHC : 10.50 (+0.86%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRTV, CTG, DBTX, CPRI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

VRTV : 169.99 (+0.02%)
CTG : 10.50 (+0.10%)
CPRI : 18.53 (-0.86%)
DBTX : 4.91 (-0.81%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMNB, DBTX, TRHC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

DBTX : 4.91 (-0.81%)
AMNB : 47.76 (-0.33%)
TRHC : 10.50 (+0.86%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRHC, DBTX, VRTV, ZYNE

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

VRTV : 169.99 (+0.02%)
ZYNE : 1.3000 (+2.36%)
DBTX : 4.91 (-0.81%)
TRHC : 10.50 (+0.86%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTG, DBTX, WMC, MITT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CTG : 10.50 (+0.10%)
MITT : 7.99 (+1.65%)
WMC : 9.18 (+4.44%)
DBTX : 4.91 (-0.81%)
Shareholder Alert: Ademi LLP investigates whether Decibel Therapeutics, Inc. has obtained a Fair Price in its transaction with Regeneron

/PRNewswire/ -- Ademi LLP is investigating Decibel (NASDAQ: DBTX) for possible breaches of fiduciary duty and other violations of law in its transaction with...

DBTX : 4.91 (-0.81%)
Housing, Manufacturing Stats Due Next Week

Housing, Manufacturing Stats Due Next Week Monday U.S. Featured EarningsGitLab Inc. ...

GTLB : 25.98 (+0.23%)
DG : 113.29 (-2.73%)
JANX : 14.18 (-2.51%)
GOL : 2.72 (+3.23%)
DLO : 13.70 (-0.36%)
SMAR : 56.47 (+0.02%)
CJ.TO : 12.29 (+1.40%)
FIVE : 223.13 (+0.85%)
ATD.TO : 79.23 (+0.30%)
S : 16.59 (+4.21%)
LEN : 88.38 (+0.73%)
JBL : 355.15 (+1.59%)
Decibel Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Update

- Announced positive data from interim analysis of Phase 1b clinical trial of DB-020 in patients receiving cisplatin chemotherapy; data support continued...

DBTX : 4.91 (-0.81%)
Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy

- 87% of patients who experienced ototoxicity in their placebo-treated ear were protected from ototoxicity in their DB-020-treated ear – - Data support...

DBTX : 4.91 (-0.81%)

Barchart Exclusives

Palantir Stock Has a ‘High-Class Problem’: Demand for Its Software Is Far Outpacing Supply
Palantir’s greatest challenge may no longer be demand, but how quickly it can deliver AI software to customers. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.